+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neomycin"

From
From
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Aminoglycosides Market Report 2025 - Product Thumbnail Image

Aminoglycosides Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Aminoglycosides - Global Strategic Business Report - Product Thumbnail Image

Aminoglycosides - Global Strategic Business Report

  • Report
  • May 2025
  • 402 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Neomycin is an antibiotic used to treat a variety of bacterial infections. It is a member of the aminoglycoside class of antibiotics, which are derived from Streptomyces bacteria. Neomycin is effective against a wide range of Gram-positive and Gram-negative bacteria, and is often used in combination with other antibiotics. It is commonly used to treat skin and eye infections, as well as gastrointestinal and urinary tract infections. Neomycin is also used in topical preparations to treat skin infections and as an additive in animal feed to prevent bacterial growth. Neomycin is available in a variety of formulations, including tablets, capsules, ointments, creams, and injectable solutions. It is also available as a generic drug, as well as under brand names such as Neo-Fradin, Mycifradin, and Neo-Tab. Some companies in the Neomycin market include Pfizer, Merck, Sanofi, Bayer, and Novartis. Show Less Read more